Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1111

Similar articles for PubMed (Select 19827886)

1.

Filgrastim and antibiotics treatment reduces neutropenia severity in solid cancer patients.

Hassan BA, Yusoff ZB, Othman SB.

Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):641-4.

2.

Retrospective comparison of neutropenia in children with Ewing sarcoma treated with chemotherapy and granulocyte colony-stimulating factor (G-CSF) or pegylated G-CSF.

Milano-Bausset E, Gaudart J, Rome A, Coze C, Gentet JC, Padovani L, Lacarelle B, André N.

Clin Ther. 2009;31 Pt 2:2388-95. doi: 10.1016/j.clinthera.2009.11.013.

PMID:
20110048
3.
4.
5.

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.

Maher DW, Lieschke GJ, Green M, Bishop J, Stuart-Harris R, Wolf M, Sheridan WP, Kefford RF, Cebon J, Olver I, McKendrick J, Toner G, Bradstock K, Lieschke M, Cruickshank S, Tomita DK, Hoffman EW, Fox RM, Morstyn G.

Ann Intern Med. 1994 Oct 1;121(7):492-501.

PMID:
7520676
6.

Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia.

Frampton JE, Lee CR, Faulds D.

Drugs. 1994 Nov;48(5):731-60. Review.

PMID:
7530630
7.

Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.

Weycker D, Malin J, Kim J, Barron R, Edelsberg J, Kartashov A, Oster G.

Clin Ther. 2009 May;31(5):1069-81. doi: 10.1016/j.clinthera.2009.05.019.

PMID:
19539108
8.

Granulocytic growth factors and cancer-related neutropenia: limited effects.

[No authors listed]

Prescrire Int. 2006 Oct;15(85):189-91.

PMID:
17128529
9.
10.

Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients.

Mitchell PL, Morland B, Stevens MC, Dick G, Easlea D, Meyer LC, Pinkerton CR.

J Clin Oncol. 1997 Mar;15(3):1163-70.

PMID:
9060560
12.
13.

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.

Aapro MS, Cameron DA, Pettengell R, Bohlius J, Crawford J, Ellis M, Kearney N, Lyman GH, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C; European Organisation for Research and Treatment of Cancer (EORTC) Granulocyte Colony-Stimulating Factor (G-CSF) Guidelines Working Party.

Eur J Cancer. 2006 Oct;42(15):2433-53. Epub 2006 Jun 5. Review.

PMID:
16750358
14.

Safety and efficacy of pegfilgrastim in children with cancer receiving myelosuppressive chemotherapy.

André N, Kababri ME, Bertrand P, Rome A, Coze C, Gentet JC, Bernard JL.

Anticancer Drugs. 2007 Mar;18(3):277-81.

PMID:
17264759
16.

A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia.

Lalami Y, Paesmans M, Aoun M, Munoz-Bermeo R, Reuss K, Cherifi S, Alexopoulos CG, Klastersky J.

Support Care Cancer. 2004 Oct;12(10):725-30.

PMID:
15235901
17.

An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma.

Michon JM, Hartmann O, Bouffet E, Meresse V, Coze C, Rubie H, Bordigoni P, Cattiaux E, Ward N, Bernard JL, Lemerle J, Zucker JM, Philip T.

Eur J Cancer. 1998 Jun;34(7):1063-9.

PMID:
9849455
19.

Filgrastim in patients with neutropenia: potential effects on quality of life.

Lyman GH, Kuderer NM.

Drugs. 2002;62 Suppl 1:65-78. Review.

PMID:
12479595
20.

Optimizing the management of chemotherapy-induced neutropenia.

Dale DC.

Clin Adv Hematol Oncol. 2003 Nov;1(11):679-84. Review.

PMID:
16258470
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk